The Substance Abuse and Mental Health Services Administration (SAMHSA) has expedited its process to release emergency grants to strengthen access to treatments for substance use disorders and serious mental illness during the COVID-19 pandemic. SAMHSA has also updated its list of Frequently Asked Questions about provision of methadone and buprenorphine for treatment of opioid use disorder during the emergency.